• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧自富集纳米囊泡的集成平台:SP94 肽导向的肝癌化学/声动力治疗。

Integrated platform of oxygen self-enriched nanovesicles: SP94 peptide-directed chemo/sonodynamic therapy for liver cancer.

机构信息

Department of Pharmaceutics, Daqing Campus, Harbin Medical University, Key Laboratory of Research and Development of Natural Products at Harbin Medical University, 39 Xin Yang Road, Daqing 163319, China.

Department of Pharmaceutical Engineering, China Pharmaceutical University, 639 Longmian Rd, Nanjing 211198, China.

出版信息

Eur J Pharm Biopharm. 2022 Oct;179:206-220. doi: 10.1016/j.ejpb.2022.09.012. Epub 2022 Sep 21.

DOI:10.1016/j.ejpb.2022.09.012
PMID:36150614
Abstract

Hepatocellular carcinoma (HCC) is a most common primary liver cancer among the most deadly malignancies. Selectively killing the cancer cells within the liver urgently requires the novel treatment strategies. The combination of sonodynamic therapy (SDT) and chemotherapy based on the nanotechnology have achieved some achievements in the HCC treatments. However, off-targeting drug delivery to healthy cells and the hypoxic microenvironment in the solid tumors frustrate the efforts to the combined strategy. The hypoxic microenvironment restrains the generation of ROS, leading to the decreased effects of SDT. To improve the clinical outcomes of chemo/SDT strategy, we created a novel oxygen self-enriched active targeted nanovesicle (ICG-DOX NPs/PFH@SP94-Lip). SP94 peptide could enhance the selectivity of the nanovesicles to liver tumor cells rather than normal liver cells. Besides, an oxygen carrier, perfluorohexanes (PFH), was co-loaded into liposomes to increase the oxygen level in tumor tissue, thus improving the effects of SDT. The in vivo studies showed that the ICG-DOX NPs/PFH@SP94-Lip combined with the external US stimulation significantly inhibited effects on tumor growth. Therefore, this novel oxygen self-enriched chemo/SDT nanocomposites represents a proof-of-concept liver tumor treatment strategy.

摘要

肝细胞癌(HCC)是最常见的原发性肝癌,也是最致命的恶性肿瘤之一。迫切需要新的治疗策略来选择性地杀死肝脏内的癌细胞。基于纳米技术的声动力学疗法(SDT)和化疗的联合已经在 HCC 治疗中取得了一些成果。然而,药物靶向非肿瘤细胞和实体瘤中的缺氧微环境阻碍了联合策略的发展。缺氧微环境抑制了 ROS 的产生,导致 SDT 效果降低。为了提高化疗/SDT 策略的临床效果,我们构建了一种新型的氧自富活性靶向纳米囊泡(ICG-DOX NPs/PFH@SP94-Lip)。SP94 肽可以增强纳米囊泡对肝癌细胞的选择性,而不是正常肝细胞。此外,载氧剂全氟己烷(PFH)被共载入脂质体中,以增加肿瘤组织中的氧水平,从而提高 SDT 的效果。体内研究表明,ICG-DOX NPs/PFH@SP94-Lip 联合外部超声刺激显著抑制了肿瘤生长。因此,这种新型的氧自富化疗/SDT 纳米复合材料代表了一种肝癌治疗的概念验证策略。

相似文献

1
Integrated platform of oxygen self-enriched nanovesicles: SP94 peptide-directed chemo/sonodynamic therapy for liver cancer.氧自富集纳米囊泡的集成平台:SP94 肽导向的肝癌化学/声动力治疗。
Eur J Pharm Biopharm. 2022 Oct;179:206-220. doi: 10.1016/j.ejpb.2022.09.012. Epub 2022 Sep 21.
2
Modulation of Tumor Hypoxia by pH-Responsive Liposomes to Inhibit Mitochondrial Respiration for Enhancing Sonodynamic Therapy.通过 pH 响应脂质体调节肿瘤缺氧以抑制线粒体呼吸增强声动力学治疗。
Int J Nanomedicine. 2020 Aug 6;15:5687-5700. doi: 10.2147/IJN.S256038. eCollection 2020.
3
SP94 peptide mediating highly specific and efficacious delivery of polymersomal doxorubicin hydrochloride to hepatocellular carcinoma in vivo.SP94 肽介导聚合物胶束盐酸多柔比星体内对肝癌的高效特异性递送。
Colloids Surf B Biointerfaces. 2021 Jan;197:111399. doi: 10.1016/j.colsurfb.2020.111399. Epub 2020 Oct 5.
4
Sonosensitizer Nanoplatforms Augmented Sonodynamic Therapy-Sensitizing Shikonin-Induced Necroptosis Against Hepatocellular Carcinoma.声敏剂纳米平台增强声动力学疗法-紫草素诱导的肝细胞癌坏死性凋亡。
Int J Nanomedicine. 2023 Nov 28;18:7079-7092. doi: 10.2147/IJN.S435104. eCollection 2023.
5
Perfluorohexane-Loaded Polymeric Nanovesicles with Oxygen Supply for Enhanced Sonodynamic Therapy.载全氟己烷的聚合物纳米囊泡供氧用于增强声动力学治疗。
ACS Biomater Sci Eng. 2020 May 11;6(5):2956-2969. doi: 10.1021/acsbiomaterials.0c00407. Epub 2020 Apr 7.
6
RNA-Seq Explores the Mechanism of Oxygen-Boosted Sonodynamic Therapy Based on All-in-One Nanobubbles to Enhance Ferroptosis for the Treatment of HCC.RNA-Seq 探索基于一体化纳米气泡的氧增强声动力学疗法增强铁死亡治疗 HCC 的机制。
Int J Nanomedicine. 2022 Jan 7;17:105-123. doi: 10.2147/IJN.S343361. eCollection 2022.
7
In Vitro and In Vivo Evaluation of SP94 Modified Liposomes Loaded with N-14NCTDA, a Norcantharimide Derivative for Hepatocellular Carcinoma-Targeting.体外和体内评价 SP94 修饰的载 N-14NCTDA 脂质体用于肝癌靶向治疗。
AAPS PharmSciTech. 2020 Oct 8;21(7):277. doi: 10.1208/s12249-020-01829-3.
8
Cationic Polythiophene as Gene Carrier and Sonosensitizer for Sonodynamic Synergic Gene Therapy of Hepatocellular Carcinoma.阳离子聚噻吩作为基因载体和声敏剂用于肝癌的声动力学协同基因治疗。
ACS Biomater Sci Eng. 2024 Jul 8;10(7):4601-4611. doi: 10.1021/acsbiomaterials.4c00704. Epub 2024 Jun 7.
9
Sinoporphyrin sodium based sonodynamic therapy induces anti-tumor effects in hepatocellular carcinoma and activates p53/caspase 3 axis.血卟啉单甲醚钠介导的声动力学疗法在肝癌中诱导抗肿瘤作用,并激活 p53/caspase 3 通路。
Int J Biochem Cell Biol. 2019 Aug;113:104-114. doi: 10.1016/j.biocel.2019.01.009. Epub 2019 Jan 17.
10
Iron oxide nanoparticles as nanocarriers to improve chlorin e6-based sonosensitivity in sonodynamic therapy.氧化铁纳米颗粒作为纳米载体用于提高声动力疗法中基于二氢卟吩e6的声敏化作用
Drug Des Devel Ther. 2018 Dec 10;12:4207-4216. doi: 10.2147/DDDT.S184679. eCollection 2018.

引用本文的文献

1
Sorafenib-Drug Delivery Strategies in Primary Liver Cancer.索拉非尼在原发性肝癌中的药物递送策略。
J Funct Biomater. 2025 Apr 21;16(4):148. doi: 10.3390/jfb16040148.
2
Optimizing Triple-Negative Breast Cancer Therapy via Ultrasound-Enhanced Piezocatalysis for Targeted Chemodrug Release.通过超声增强压电催化实现靶向化疗药物释放以优化三阴性乳腺癌治疗
Int J Nanomedicine. 2025 Mar 6;20:2779-2796. doi: 10.2147/IJN.S505526. eCollection 2025.
3
The abscopal effects of sonodynamic therapy in cancer.声动力疗法在癌症中的远隔效应。
Br J Cancer. 2025 Mar;132(5):409-420. doi: 10.1038/s41416-024-02898-y. Epub 2024 Nov 13.